Blood Banking (Safety)

Hold on Clotting Factor Lifted After No HIV Found

Published in Blood Weekly, March 17th, 1997

Alpha Therapeutic Corp., Los Angeles, California, lifted the nationwide hold on a blood clotting factor that was withdrawn from the market when it was thought to be infected with HIV.

Patients with a rare form of hemophilia again can use Profilnine SD, a Factor IX concentrate drawn from plasma, the company announced. The product is one of several available to the 1,500 to 3,000 Americans suffering from the rare hemophilia B, known as Christmas disease.

The lot, labeled CS6210A, was quarantined on February 18, 1997, after it was found to have come from a plasma pool that showed possible signs of HIV antibodies. A single inconclusive test result...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1997-03-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry